Role of activins in hepcidin regulation during malaria

Infection and Immunity

Volumn 85, Issue 12, 2017, Pages

  Spottiswoode, Natasha ^a,b   Armitage, Andrew E ^a   Williams, Andrew R ^c,d   Fyfe, Alex J ^d   Biswas, Sumi ^d   Hodgson, Susanne H ^d   Llewellyn, David ^d   Choudhary, Prateek ^d   Draper, Simon J ^d   Duffy, Patrick E ^b   Drakesmith, Hal ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Hepcidin; Innate immunity; Iron; Malaria

Indexed keywords

6 [4 (1 PIPERAZINYL)PHENYL] 3 (4 QUINOLINYL)PYRAZOLO[1,5 A]PYRIMIDINE; ACTIVIN A; ACTIVIN A ANTIBODY; ACTIVIN B ANTIBODY; ALK2 PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN 9; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; C REACTIVE PROTEIN; DORSOMORPHIN; FERRITIN; FOLLISTATIN; HAMP1 PROTEIN; HEPCIDIN; INHIBITOR OF DIFFERENTIATION 1; IRON; MESSENGER RNA; MYELOPID; NEUTRALIZING ANTIBODY; PEPTIDE HORMONE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN PRECURSOR; SMAD PROTEIN; STAT3 PROTEIN; TRANSFERRIN; UNCLASSIFIED DRUG; ACTIVIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HEP-G2 CELL LINE; HUMAN; HUMAN CELL; INFLAMMATION; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON METABOLISM; LIVER; MALARIA; MALE; METABOLIC REGULATION; MOUSE; NONHUMAN; NORMAL HUMAN; PARASITE LOAD; PARASITE VIRULENCE; PARASITEMIA; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; PLASMODIUM CHABAUDI; PLASMODIUM CHABAUDI INFECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIGNAL TRANSDUCTION; UNSATURATED IRON BINDING CAPACITY; UPREGULATION; ANIMAL; DISEASE MODEL; GENE EXPRESSION REGULATION; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PATHOLOGY;

ACTIVINS; ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HEPCIDINS; HUMANS; MALARIA; MICE; PLASMODIUM BERGHEI; PLASMODIUM CHABAUDI;

EID: 85034013787     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00191-17     Document Type: Article

References (74)

1. WHO. 2015. World malaria report 2015. WHO, Geneva, Switzerland
2. Kassebaum NJ, Jasrasaria R, Naghavi M, Wulf SK, Johns N, Lozano R, Regan M, Weatherall D, Chou DP, Eisele TP, Flaxman SR, Pullan RL, Brooker SJ, Murray CJ. 2014. A systematic analysis of global anemia burden from 1990 to 2010. Blood 123:615-624. https://doi.org/10.1182/ blood-2013-06-508325
3. Meremikwu MM, Donegan S, Sinclair D, Esu E, Oringanje C. 2012. Intermittent preventive treatment for malaria in children living in areas with seasonal transmission. Cochrane Database Syst Rev 2:CD003756
4. Nweneka CV, Doherty CP, Cox S, Prentice A. 2010. Iron delocalisation in the pathogenesis of malarial anaemia. Trans R Soc Trop Med Hyg 104:175-184. https://doi.org/10.1016/j.trstmh.2009.08.007
5. Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, Adermann K. 2000. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480:147-150. https:// doi.org/10.1016/S0014-5793(00)01920-7
6. Park CH, Valore EV, Waring AJ, Ganz T. 2001. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276:7806-7810. https://doi.org/10.1074/jbc.M008922200
7. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loreal O. 2001 A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276:7811-7819. https://doi.org/10.1074/jbc.M008923200
8. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J. 2004. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090-2093. https://doi.org/10.1126/science.1104742
9. Abboud S, Haile DJ. 2000. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 275:19906-19912. https://doi.org/10.1074/jbc.M000713200
10. Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Robine S, Andrews NC. 2005 The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab 1:191-200. https://doi.org/10.1016/j.cmet.2005.01.003
11. McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, Hediger MA, Hentze MW, Simpson RJ. 2000 A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5:299-309. https://doi.org/10.1016/S1097-2765(00)80425-6
12. Armitage AE, Eddowes LA, Gileadi U, Cole S, Spottiswoode N, Selvakumar TA, Ho LP, Townsend AR, Drakesmith H. 2011. Hepcidin regulation by innate immune and infectious stimuli. Blood 118:4129-4139. https:// doi.org/10.1182/blood-2011-04-351957
13. Darton TC, Blohmke CJ, Giannoulatou E, Waddington CS, Jones C, Sturges P, Webster C, Drakesmith H, Pollard AJ, Armitage AE. 2015. Rapidly escalating hepcidin and associated serum iron starvation are features of the acute response to typhoid infection in humans. PLoS Negl Trop Dis 9:e0004029. https://doi.org/10.1371/journal.pntd.0004029
14. Armitage AE, Stacey AR, Giannoulatou E, Marshall E, Sturges P, Chatha K, Smith NM, Huang X, Xu X, Pasricha SR, Li N, Wu H, Webster C, Prentice AM, Pellegrino P, Williams I, Norris PJ, Drakesmith H, Borrow P. 2014. Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections. Proc Natl Acad Sci U S A 111:12187-12192. https://doi.org/10.1073/pnas.1402351111
15. Arezes J, Jung G, Gabayan V, Valore E, Ruchala P, Gulig PA, Ganz T, Nemeth E, Bulut Y. 2015. Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus. Cell Host Microbe 17:47-57. https://doi.org/10.1016/j.chom.2014.12.001
16. de Mast Q, Nadjm B, Reyburn H, Kemna EH, Amos B, Laarakkers CM, Silalye S, Verhoef H, Sauerwein RW, Swinkels DW, van der Ven AJ. 2009. Assessment of urinary concentrations of hepcidin provides novel insight into disturbances in iron homeostasis during malarial infection. J Infect Dis 199:253-262. https://doi.org/10.1086/595790
17. Howard CT, McKakpo US, Quakyi IA, Bosompem KM, Addison EA, Sun K, Sullivan D, Semba RD. 2007. Relationship of hepcidin with parasitemia and anemia among patients with uncomplicated Plasmodium falciparum malaria in Ghana. Am J Trop Med Hyg 77:623-626
18. de Mast Q, Syafruddin D, Keijmel S, Riekerink TO, Deky O, Asih PB, Swinkels DW, van der Ven AJ. 2010. Increased serum hepcidin and alterations in blood iron parameters associated with asymptomatic P. falciparum and P. vivax malaria. Haematologica 95:1068-1074. https:// doi.org/10.3324/haematol.2009.019331
19. de Mast Q, van Dongen-Lases EC, Swinkels DW, Nieman AE, Roestenberg M, Druilhe P, Arens TA, Luty AJ, Hermsen CC, Sauerwein RW, van der Ven AJ. 2009. Mild increases in serum hepcidin and interleukin-6 concentrations impair iron incorporation in haemoglobin during an experimental human malaria infection. Br J Haematol 145:657-664. https://doi.org/10.1111/j.1365-2141.2009.07664.x
20. Portugal S, Carret C, Recker M, Armitage AE, Goncalves LA, Epiphanio S, Sullivan D, Roy C, Newbold CI, Drakesmith H, Mota MM. 2011. Hostmediated regulation of superinfection in malaria. Nat Med 17:732-737. https://doi.org/10.1038/nm.2368
21. Wang HZ, He YX, Yang CJ, Zhou W, Zou CG. 2011. Hepcidin is regulated during blood-stage malaria and plays a protective role in malaria infection. J Immunol 187:6410-6416. https://doi.org/10.4049/jimmunol.1101436
22. Cercamondi CI, Egli IM, Ahouandjinou E, Dossa R, Zeder C, Salami L, Tjalsma H, Wiegerinck E, Tanno T, Hurrell RF, Hounhouigan J, Zimmermann MB. 2010. Afebrile Plasmodium falciparum parasitemia decreases absorption of fortification iron but does not affect systemic iron utilization: a double stable-isotope study in young Beninese women. Am J Clin Nutr 92:1385-1392. https://doi.org/10.3945/ajcn.2010.30051
23. Prentice AM, Doherty CP, Abrams SA, Cox SE, Atkinson SH, Verhoef H, Armitage AE, Drakesmith H. 2012. Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children. Blood 119: 1922-1928. https://doi.org/10.1182/blood-2011-11-391219
24. van Santen S, de Mast Q, Swinkels DW, van der Ven AJ. 2013. The iron link between malaria and invasive non-typhoid Salmonella infections. Trends Parasitol 29:220-227. https://doi.org/10.1016/j.pt.2013.03.006
25. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, Vaulont S. 2002. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Investig 110:1037-1044. https://doi.org/10.1172/JCI0215686
26. Muckenthaler MU, Rivella S, Hentze MW, Galy B. 2017. A red carpet for iron metabolism. Cell 168:344-361. https://doi.org/10.1016/j.cell.2016.12.034
27. Kautz L, Jung G, Valore EV, Rivella S, Nemeth E, Ganz T. 2014. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet 46:678-684. https://doi.org/10.1038/ng.2996
28. Wang CY, Core AB, Canali S, Zumbrennen-Bullough KB, Ozer S, Umans L, Zwijsen A, Babitt JL. 2017. Smad1/5 is required for erythropoietinmediated suppression of hepcidin in mice. Blood 130:73-83. https://doi.org/10.1182/blood-2016-12-759423
29. Besson-Fournier C, Latour C, Kautz L, Bertrand J, Ganz T, Roth MP, Coppin H. 2012. Induction of activin B by inflammatory stimuli upregulates expression of the iron-regulatory peptide hepcidin through Smad1/5/8 signaling. Blood 120:431-439. https://doi.org/10.1182/blood-2012-02-411470
30. Jones KL, Mansell A, Patella S, Scott BJ, Hedger MP, de Kretser DM, Phillips DJ. 2007. Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. Proc Natl Acad Sci U S A 104:16239-16244. https://doi.org/10.1073/pnas.0705971104
31. Besson-Fournier C, Gineste A, Latour C, Gourbeyre O, Meynard D, Martin P, Oswald E, Coppin H, Roth MP. 2017. Hepcidin upregulation by inflammation is independent of Smad1/5/8 signaling by activin B. Blood 129:533-536. https://doi.org/10.1182/blood-2016-10-748541
32. Canali S, Core AB, Zumbrennen-Bullough KB, Merkulova M, Wang CY, Schneyer AL, Pietrangelo A, Babitt JL. 2016. Activin B induces noncanonical SMAD1/5/8 signaling via BMP type I receptors in hepatocytes: evidence for a role in hepcidin induction by inflammation in male mice. Endocrinology 157:1146-1162. https://doi.org/10.1210/en.2015-1747
33. Babitt JL, Huang FW, Xia Y, Sidis Y, Andrews NC, Lin HY. 2007. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J Clin Investig 117:1933-1939. https://doi.org/10.1172/ JCI31342
34. Kanamori Y, Sugiyama M, Hashimoto O, Murakami M, Matsui T, Funaba M. 2016. Regulation of hepcidin expression by inflammation-induced activin B. Sci Rep 6:38702. https://doi.org/10.1038/srep38702
35. Hollnagel A, Oehlmann V, Heymer J, Ruther U, Nordheim A. 1999. Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J Biol Chem 274:19838-19845. https://doi.org/10.1074/jbc.274.28.19838
36. Meynard D, Kautz L, Darnaud V, Canonne-Hergaux F, Coppin H, Roth MP. 2009 Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet 41:478-481. https://doi.org/10.1038/ng.320
37. Andriopoulos B, Jr, Corradini E, Xia Y, Faasse SA, Chen S, Grgurevic L, Knutson MD, Pietrangelo A, Vukicevic S, Lin HY, Babitt JL. 2009. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet 41:482-487. https://doi.org/10.1038/ng.335
38. Tanno T, Porayette P, Sripichai O, Noh SJ, Byrnes C, Bhupatiraju A, Lee YT, Goodnough JB, Harandi O, Ganz T, Paulson RF, Miller JL. 2009. Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood 114:181-186. https://doi.org/10.1182/blood-2008-12-195503
39. Grcevic D, Kusec R, Kovacic N, Lukic A, Lukic IK, Ivcevic S, Nemet D, Seiwerth RS, Ostojic SK, Croucher PI, Marusic A. 2010. Bone morphogenetic proteins and receptors are over-expressed in bone-marrow cells of multiple myeloma patients and support myeloma cells by inducing ID genes. Leuk Res 34:742-751. https://doi.org/10.1016/j.leukres.2009.10.016
40. Maes K, Nemeth E, Roodman GD, Huston A, Esteve F, Freytes C, Callander N, Katodritou E, Tussing-Humphreys L, Rivera S, Vanderkerken K, Lichtenstein A, Ganz T. 2010. In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2. Blood 116: 3635-3644. https://doi.org/10.1182/blood-2010-03-274571
41. Koch PS, Olsavszky V, Ulbrich F, Sticht C, Demory A, Leibing T, Henzler T, Meyer M, Zierow J, Schneider S, Breitkopf-Heinlein K, Gaitantzi H, Spencer-Dene B, Arnold B, Klapproth K, Schledzewski K, Goerdt S, Geraud C. 2017. Angiocrine Bmp2 signaling in murine liver controls normal iron homeostasis. Blood 129:415-419. https://doi.org/10.1182/blood-2016-07-729822
42. Wu H, Chen Y, Winnall WR, Phillips DJ, Hedger MP. 2012. Acute regulation of activin A and its binding protein, follistatin, in serum and tissues following lipopolysaccharide treatment of adult male mice. Am J Physiol Regul Integr Comp Physiol 303:R665-R675. https://doi.org/10.1152/ ajpregu.00478.2011
43. Chang KH, Stevenson MM. 2004. Malarial anaemia: mechanisms and implications of insufficient erythropoiesis during blood-stage malaria. Int J Parasitol 34:1501-1516. https://doi.org/10.1016/j.ijpara.2004.10.008
44. Robson NC, Phillips DJ, McAlpine T, Shin A, Svobodova S, Toy T, Pillay V, Kirkpatrick N, Zanker D, Wilson K, Helling I, Wei H, Chen W, Cebon J, Maraskovsky E. 2008. Activin-A: a novel dendritic cell-derived cytokine that potently attenuates CD40 ligand-specific cytokine and chemokine production. Blood 111:2733-2743. https://doi.org/10.1182/blood-2007-03-080994
45. Eramaa M, Hurme M, Stenman UH, Ritvos O. 1992. Activin A/erythroid differentiation factor is induced during human monocyte activation. J Exp Med 176:1449-1452. https://doi.org/10.1084/jem.176.5.1449
46. Armitage AE, Pinches R, Eddowes LA, Newbold CI, Drakesmith H. 2009. Plasmodium falciparum infected erythrocytes induce hepcidin (HAMP) mRNA synthesis by peripheral blood mononuclear cells. Br J Haematol 147:769-771. https://doi.org/10.1111/j.1365-2141.2009.07880.x
47. Cuny GD, Yu PB, Laha JK, Xing X, Liu JF, Lai CS, Deng DY, Sachidanandan C, Bloch KD, Peterson RT. 2008. Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors. Bioorg Med Chem Lett 18:4388-4392. https://doi.org/10.1016/j.bmcl.2008.06.052
48. Murakami M, Ikeda T, Saito T, Ogawa K, Nishino Y, Nakaya K, Funaba M. 2006 Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factor-beta, activin A and microphthalmiaassociated transcription factor. Cell Signal 18:256-265. https://doi.org/ 10.1016/j.cellsig.2005.04.010
49. Zhao H, Konishi A, Fujita Y, Yagi M, Ohata K, Aoshi T, Itagaki S, Sato S, Narita H, Abdelgelil NH, Inoue M, Culleton R, Kaneko O, Nakagawa A, Horii T, Akira S, Ishii KJ, Coban C. 2012. Lipocalin 2 bolsters innate and adaptive immune responses to blood-stage malaria infection by reinforcing host iron metabolism. Cell Host Microbe 12:705-716. https://doi.org/10.1016/j.chom.2012.10.010
50. Casals-Pascual C, Huang H, Lakhal-Littleton S, Thezenas ML, Kai O, Newton CR, Roberts DJ. 2012. Hepcidin demonstrates a biphasic association with anemia in acute Plasmodium falciparum malaria. Haematologica 97:1695-1698. https://doi.org/10.3324/haematol.2012.065854
51. Latour C, Wlodarczyk MF, Jung G, Gineste A, Blanchard N, Ganz T, Roth MP, Coppin H, Kautz L. 2017. Erythroferrone contributes to hepcidin repression in a mouse model of malarial anemia. Haematologica 102: 60-68. https://doi.org/10.3324/haematol.2016.150227
52. Jonker FA, Calis JC, van Hensbroek MB, Phiri K, Geskus RB, Brabin BJ, Leenstra T. 2012. Iron status predicts malaria risk in Malawian preschool children. PLoS One 7:e42670. https://doi.org/10.1371/journal.pone.0042670
53. Burte F, Brown BJ, Orimadegun AE, Ajetunmobi WA, Afolabi NK, Akinkunmi F, Kowobari O, Omokhodion S, Osinusi K, Akinbami FO, Shokunbi WA, Sodeinde O, Fernandez-Reyes D. 2013. Circulatory hepcidin is associated with the anti-inflammatory response but not with iron or anemic status in childhood malaria. Blood 121:3016-3022. https://doi.org/10.1182/blood-2012-10-461418
54. Locci M, Wu JE, Arumemi F, Mikulski Z, Dahlberg C, Miller AT, Crotty S. 2016 Activin A programs the differentiation of human TFH cells. Nat Immunol 17:976-984. https://doi.org/10.1038/ni.3494
55. Michel U, Ebert S, Phillips D, Nau R. 2003. Serum concentrations of activin and follistatin are elevated and run in parallel in patients with septicemia. Eur J Endocrinol 148:559-564. https://doi.org/10.1530/eje.0.1480559
56. Petrakou E, Fotopoulos S, Anagnostakou M, Anatolitou F, Samitas K, Semitekolou M, Xanthou G, Xanthou M. 2013. Activin-A exerts a crucial anti-inflammatory role in neonatal infections. Pediatr Res 74:675-681. https://doi.org/10.1038/pr.2013.159
57. Jones KL, de Kretser DM, Clarke IJ, Scheerlinck JP, Phillips DJ. 2004. Characterisation of the rapid release of activin A following acute lipopolysaccharide challenge in the ewe. J Endocrinol 182:69-80. https:// doi.org/10.1677/joe.0.1820069
58. Wu H, Chen Y, Winnall WR, Phillips DJ, Hedger MP. 2013. Regulation of activin A release from murine bone marrow-derived neutrophil precursors by tumour necrosis factor-alpha and insulin. Cytokine 61:199-204. https://doi.org/10.1016/j.cyto.2012.09.018
59. Hedger MP, Winnall WR, Phillips DJ, de Kretser DM. 2011. The regulation and functions of activin and follistatin in inflammation and immunity. Vitam Horm 85:255-297. https://doi.org/10.1016/B978-0-12-385961-7.00013-5
60. Mason AJ, Berkemeier LM, Schmelzer CH, Schwall RH. 1989. Activin B: precursor sequences, genomic structure and in vitro activities. Mol Endocrinol 3:1352-1358. https://doi.org/10.1210/mend-3-9-1352
61. Phillips DJ, Brauman JN, Mason AJ, de Kretser DM, Hedger MP. 1999. A sensitive and specific in vitro bioassay for activin using a mouse plasmacytoma cell line, MPC-11. J Endocrinol 162:111-116. https://doi.org/ 10.1677/joe.0.1620111
62. Brown CW, Houston-Hawkins DE, Woodruff TK, Matzuk MM. 2000. Insertion of Inhbb into the Inhba locus rescues the Inhba-null phenotype and reveals new activin functions. Nat Genet 25:453-457. https://doi.org/10.1038/78161
63. Brown CW, Li L, Houston-Hawkins DE, Matzuk MM. 2003. Activins are critical modulators of growth and survival. Mol Endocrinol 17: 2404-2417. https://doi.org/10.1210/me.2003-0051
64. Bonomi L, Brown M, Ungerleider N, Muse M, Matzuk MM, Schneyer A. 2012 Activin B regulates islet composition and islet mass but not whole body glucose homeostasis or insulin sensitivity. Am J Physiol Endocrinol Metab 303:E587-E596. https://doi.org/10.1152/ajpendo.00177.2012
65. Ludlow H, Phillips DJ, Myers M, McLachlan RI, de Kretser DM, Allan CA, Anderson RA, Groome NP, Hyvonen M, Duncan WC, Muttukrishna S. 2009 A new 'total' activin B enzyme-linked immunosorbent assay (ELISA): development and validation for human samples. Clin Endocrinol (Oxf) 71:867-873. https://doi.org/10.1111/j.1365-2265.2009.03567.x
66. de Kretser DM, Bensley JG, Pettila V, Linko R, Hedger MP, Hayward S, Allan CA, McLachlan RI, Ludlow H, Phillips DJ. 2013. Serum activin A and B levels predict outcome in patients with acute respiratory failure: a prospective cohort study. Crit Care 17:R263. https://doi.org/10.1186/ cc13093
67. Linko R, Hedger MP, Pettila V, Ruokonen E, Ala-Kokko T, Ludlow H, de Kretser DM. 2014. Serum activin A and B, and follistatin in critically ill patients with influenza A(H1N1) infection. BMC Infect Dis 14:253. https:// doi.org/10.1186/1471-2334-14-253
68. de Kretser DM, Bensley JG, Phillips DJ, Levvey BJ, Snell GI, Lin E, Hedger MP, O'Hehir RE. 2016. Substantial increases occur in serum activins and follistatin during lung transplantation. PLoS One 11:e0140948. https:// doi.org/10.1371/journal.pone.0140948
69. Goodman AL, Forbes EK, Williams AR, Douglas AD, de Cassan SC, Bauza K, Biswas S, Dicks MD, Llewellyn D, Moore AC, Janse CJ, Franke-Fayard BM, Gilbert SC, Hill AV, Pleass RJ, Draper SJ. 2013. The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment. Sci Rep 3:1706. https://doi.org/10.1038/srep01706
70. Kautz L, Besson-Fournier C, Meynard D, Latour C, Roth MP, Coppin H. 2011 Iron overload induces BMP6 expression in the liver but not in the duodenum. Haematologica 96:199-203. https://doi.org/10.3324/ haematol.2010.031963
71. Ewer KJ, O'Hara GA, Duncan CJ, Collins KA, Sheehy SH, Reyes-Sandoval A, Goodman AL, Edwards NJ, Elias SC, Halstead FD, Longley RJ, Rowland R, Poulton ID, Draper SJ, Blagborough AM, Berrie E, Moyle S, Williams N, Siani L, Folgori A, Colloca S, Sinden RE, Lawrie AM, Cortese R, Gilbert SC, Nicosia A, Hill AV. 2013. Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation. Nat Commun 4:2836. https://doi.org/10.1038/ncomms3836
72. Sheehy SH, Duncan CJ, Elias SC, Choudhary P, Biswas S, Halstead FD, Collins KA, Edwards NJ, Douglas AD, Anagnostou NA, Ewer KJ, Havelock T, Mahungu T, Bliss CM, Miura K, Poulton ID, Lillie PJ, Antrobus RD, Berrie E, Moyle S, Gantlett K, Colloca S, Cortese R, Long CA, Sinden RE, Gilbert SC, Lawrie AM, Doherty T, Faust SN, Nicosia A, Hill AV, Draper SJ. 2012. ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans. Mol Ther 20:2355-2368. https://doi.org/10.1038/mt.2012.223
73. Hodgson SH, Ewer KJ, Bliss CM, Edwards NJ, Rampling T, Anagnostou NA, de Barra E, Havelock T, Bowyer G, Poulton ID, de Cassan S, Longley R, Illingworth JJ, Douglas AD, Mange PB, Collins KA, Roberts R, Gerry S, Berrie E, Moyle S, Colloca S, Cortese R, Sinden RE, Gilbert SC, Bejon P, Lawrie AM, Nicosia A, Faust SN, Hill AV. 2015. Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malarianaive individuals. J Infect Dis 211:1076-1086. https://doi.org/10.1093/ infdis/jiu579
74. Atkinson SH, Armitage AE, Khandwala S, Mwangi TW, Uyoga S, Bejon PA, Williams TN, Prentice AM, Drakesmith H. 2014. Combinatorial effects of malaria season, iron deficiency and inflammation determine plasma hepcidin concentration in African children. Blood 123: 3221-3229. https://doi.org/10.1182/blood-2013-10-533000